Hello! Recent discussions highlight the booming market for weight-loss drugs like Wegovy and Zepbound, which are expected to generate up to $80 billion annually by 2030.
These medications, known as GLP-1 agonists, can reduce body weight by about 15%, or roughly 30 pounds for someone weighing 200 pounds.
With nearly half the world's population projected to be overweight or obese by 2030, the potential for massive sales is clear.
However, these drugs come with significant concerns. Historically, long-term use of powerful pharmaceuticals often leads to side effects, and weight-loss drugs are no exception. They can cause nausea, muscle loss, and diminish the enjoyment of food. The long-term effects of taking these medications for over a decade remain unknown, raising questions about their safety. Moreover, human behavior plays a crucial role. Many overweight individuals maintain healthier lifestyles through diet and exercise. If a pill could make weight management effortless, many might choose to rely solely on medication, potentially neglecting healthier habits. |
0 comentarios:
Publicar un comentario